Vanta Bioscience (BOM:540729) EV-to-FCF : -17.49 (As of Apr. 10, 2025)

Vanta Bioscience EV-to-FCF Chart

Vanta Bioscience Semi-Annual Data
	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
EV-to-FCF	Get a 7-Day Free Trial											-	-3.23	-	-137.54	-

Competitive Comparison of Vanta Bioscience's EV-to-FCF

For the Diagnostics & Research subindustry, Vanta Bioscience's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vanta Bioscience's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vanta Bioscience's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Vanta Bioscience's EV-to-FCF falls into.

Vanta Bioscience EV-to-FCF Calculation

Vanta Bioscience's EV-to-FCF for today is calculated as:

Vanta Bioscience's current Enterprise Value is ₹745.75 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vanta Bioscience's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ₹-42.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vanta Bioscience  (BOM:540729) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Vanta Bioscience's PE Ratio (TTM) for today is calculated as:

Vanta Bioscience's share price for today is ₹20.92.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vanta Bioscience's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹-6.100.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Vanta Bioscience EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Vanta Bioscience's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Vanta Bioscience Business Description